Robocath announced today that it successfully completed the first robotic coronary angioplasties on the continent of Africa with its R-One system. The Rouen, France-based company performed six successful robotic coronary angioplasties in Cape Town. Netcare Christiaan Barnard Memorial Hospital interventional cardiologist Dr. Faizel Lorgat performed the percutaneous coronary interventions as part of a distribution agreement […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Barry out as InspireMD CEO
InspireMD (NYSE:NSPR) announced today that president & CEO James Barry is stepping down, effective Dec. 31, to pursue other opportunities. InspireMD is facing a potential de-listing from the New York Stock Exchange after reporting stockholders’ equity of less than $6 million as of June 30 and net losses for the last five years. The company […]
Schiller issues field safety notice for Tempus LS defibrillators
Schiller has issued a field safety notice for its Tempus LS defibrillator for impedance out of valid range and unexpected safety discharge. The company received notice about an impedance change between a patient and the device that could cause an impairment of the impedance measurement. If the impedance is out of a valid range, defibrillation […]
Abbott issues field safety notice for Heartmate 3 LVAS power unit
Abbott (NYSE:ABT) has issued a field safety notice for its HeartMate 3 Left Ventricular Assist System mobile power unit, citing loss of power due to static electricity. The notice identifies power loss to the HeartMate Mobile Power Unit Module due to static electricity. The power unit is connected to the HeartMate 3 Left Ventricular Assist System […]
Medtronic faces patent lawsuit over CoreValve tech
A decade-old company called Colibri Heart Valve is claiming in a lawsuit that Medtronic’s CoreValve line of TAVR devices are infringing on two of its patents. Founded in 2010, Broomfield, Colo.–based Colibri boasts that its TAVI system is the only one using dry tissue technology to allow for a pre-mounted, pre-crimped, and pre-loaded heart valve, […]
Edwards projects $5 billion in sales for 2020
Wall Street expressed brief unhappiness with projections made at today’s Edwards Lifesciences (NYSE:EW) annual investor conference in New York, but shares had recovered partially by the close of trading. The Irvine, Calif.-based heart valve replacement pioneer projected adjusted EPS of $6.05 to $6.30 on global sales of $4.5 billion to $5 billion for 2020. Edwards […]
New study touts positive long-term results for Boston Sci’s Watchman
A long-term followup study on Boston Scientific’s (NYSE:BSX) Watchman heart implant shows low risk of hemorrhagic stroke and a high percentage of patients who discontinued anticoagulation drugs at one year. Published this week in the Journal of the American College of Cardiology, the new registry data represent the largest number and longest follow-up of patients […]
TransMedics touts first U.S. ‘reanimated’ heart transplants
TransMedics (NSDQ:TMDX) announced today that the doctors at two hospitals performed the first U.S. heart transplants using donor hearts that were resuscitated using the company’s organ care system (OCS). The transplants from donation after circulatory death (DCD) took place at Duke University Hospital in Durham, N.C. and Massachusetts General Hospital in Boston. In a DCD procedure, […]
Venclose closes $27m Series C
Venous reflux disease treatment developer Venclose announced that it closed a Series C funding round totaling $27 million. Venclose develops the next-generation Venclose RF ablation system designed to close damaged veins and restore healthy blood flow in patients with venous reflux disease. The San Jose, Calif.–based company said that, after securing the $27 million, it […]
Mobile ECG management? There’s a new app in the works
CardioComm Solutions (Toronto) announced today that it is working with startup Zana Technologies (Karlsruhe, Germany) to package CardioComm’s ECG reviewing and monitor technology into Zana’s mobile app and patient engagement platform. The goal is for Zana users to be able to download a single smartphone app over which they can receive ECG recordings and clinical […]
Impulse Dynamics completes $80m round
Impulse Dynamics announced today that it completed a Series D financing round with new investors providing more than $80 million to the cardiac contractility modulation (CCM) therapy developer. The company said proceeds from the funding round totaling $80.25 million will be used to facilitate U.S. commercialization of its FDA-approved Optimizer Smart implantable device for CCM […]